Journal
ONCOGENE
Volume 28, Issue 31, Pages 2796-2805Publisher
SPRINGERNATURE
DOI: 10.1038/onc.2009.139
Keywords
anchorage-independent cell growth; phenotype; expression signature; metastatic potential; heterogeneity
Funding
- NIH/NCI [5U54CA-112952-05]
- Uehara Memorial Foundation
Ask authors/readers for more resources
The oncogenic phenotype is complex, resulting from the accumulation of multiple somatic mutations that lead to the deregulation of growth regulatory and cell fate controlling activities and pathways. The ability to dissect this complexity, so as to reveal discrete aspects of the biology underlying the oncogenic phenotype, is critical to understanding the various mechanisms of disease as well as to reveal opportunities for novel therapeutic strategies. Previous work has characterized the process of anchorage-independent growth of cancer cells in vitro as a key aspect of the tumor phenotype, particularly with respect to metastatic potential. Nevertheless, it remains a major challenge to translate these cell biology findings into the context of human tumors. We previously used DNA microarray assays to develop expression signatures, which have the capacity to identify subtle distinctions in biological states and can be used to connect in vitro and in vivo states. Here we describe the development of a signature of anchorage-independent growth, show that the signature exhibits characteristics of deregulated mitochondrial function and then demonstrate that the signature identifies human tumors with the potential for metastasis. Oncogene ( 2009) 28, 2796-2805; doi:10.1038/onc.2009.139; published online 1 June 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available